KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cerence (CRNC) Research & Development (2018 - 2025)

Cerence's Research & Development history spans 8 years, with the latest figure at $24.7 million for Q4 2025.

  • For Q4 2025, Research & Development rose 18.36% year-over-year to $24.7 million; the TTM value through Dec 2025 reached $101.6 million, down 6.91%, while the annual FY2025 figure was $97.8 million, 19.58% down from the prior year.
  • Research & Development reached $24.7 million in Q4 2025 per CRNC's latest filing, down from $26.4 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $35.1 million in Q3 2023 to a low of $20.9 million in Q4 2024.
  • Average Research & Development over 5 years is $28.1 million, with a median of $28.6 million recorded in 2021.
  • Peak YoY movement for Research & Development: surged 38.86% in 2023, then plummeted 37.34% in 2024.
  • A 5-year view of Research & Development shows it stood at $25.8 million in 2021, then increased by 14.35% to $29.5 million in 2022, then increased by 12.92% to $33.3 million in 2023, then plummeted by 37.34% to $20.9 million in 2024, then increased by 18.36% to $24.7 million in 2025.
  • Per Business Quant, the three most recent readings for CRNC's Research & Development are $24.7 million (Q4 2025), $26.4 million (Q3 2025), and $27.2 million (Q2 2025).